Europe Point of Care Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Testing Products, Pregnancy and Fertility Testing Products, Coagulation Testing Products, Tumor/Cancer Marker Testing Products, Cholesterol Testing Products, Urinalysis Testing Products, Hematology Testing Products, and Other POC Products), Prescription Mode (Prescription-Based Testing and OTC Testing), and End User (Professional Diagnostic Centers, Home Care, Research Laboratories, and Others)

No. of Pages: 196    |    Report Code: TIPRE00023727    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Point of Care Diagnostics Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Point of Care Diagnostics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Point of Care Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Prevalence of Infectious Diseases
  • 5.1.2 Product Launches and Product Developments
  • 5.1.3 Increasing Number of CLIA waived POC Tests
5.2 Market Opportunities
  • 5.2.1 High Growth Opportunities in Emerging Markets
  • 5.2.2 Increasing Number of Conferences and Events
5.3 Future Trends
  • 5.3.1 Increasing Use of Home based POC Devices
5.4 Impact of Drivers and Restraints

6. Europe Point of Care Diagnostics Market Regional Analysis

6.1 Europe Point of Care Diagnostics Market Overview
6.2 Europe Point of Care Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 Europe Point of Care Diagnostics Market Forecast Analysis

7. Europe Point of Care Diagnostics Market Analysis – by Product

7.1 Glucose Monitoring Products
  • 7.1.1 Overview
  • 7.1.2 Glucose Monitoring Products: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Infectious Disease Testing Products
  • 7.2.1 Overview
  • 7.2.2 Infectious Disease Testing Products: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Cardiometabolic Testing Products
  • 7.3.1 Overview
  • 7.3.2 Cardiometabolic Testing Products: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Pregnancy and Fertility Testing Products
  • 7.4.1 Overview
  • 7.4.2 Pregnancy and Fertility Testing Products: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Coagulation Testing Products
  • 7.5.1 Overview
  • 7.5.2 Coagulation Testing Products: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Tumor/Cancer Marker Testing Products
  • 7.6.1 Overview
  • 7.6.2 Tumor/Cancer Marker Testing Products: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Cholesterol Testing Products
  • 7.7.1 Overview
  • 7.7.2 Cholesterol Testing Products: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Urinalysis Testing Products
  • 7.8.1 Overview
  • 7.8.2 Urinalysis Testing Products: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.9 Hematology Testing Products
  • 7.9.1 Overview
  • 7.9.2 Hematology Testing Products: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.10 Other POC Products
  • 7.10.1 Overview
  • 7.10.2 Other POC Products: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Point of Care Diagnostics Market Analysis – by Prescription Mode

8.1 Prescription-Based Testing
  • 8.1.1 Overview
  • 8.1.2 Prescription-Based Testing: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2 OTC Testing
  • 8.2.1 Overview
  • 8.2.2 OTC Testing: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Point of Care Diagnostics Market Analysis – by End User

9.1 Professional Diagnostic Centers
  • 9.1.1 Overview
  • 9.1.2 OTC Testing: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Home Care
  • 9.2.1 Overview
  • 9.2.2 OTC Testing: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Research Laboratories
  • 9.3.1 Overview
  • 9.3.2 OTC Testing: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Point of Care Diagnostics Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Point of Care Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 Europe Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 UK: Europe Point of Care Diagnostics Market Breakdown, by Product
    • 10.1.1.1.2 UK: Europe Point of Care Diagnostics Market Breakdown, by Prescription Mode
    • 10.1.1.1.3 UK: Europe Point of Care Diagnostics Market Breakdown, by End User
  • 10.1.1.2 Germany: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Point of Care Diagnostics Market Breakdown, by Product
    • 10.1.1.2.2 Germany: Europe Point of Care Diagnostics Market Breakdown, by Prescription Mode
    • 10.1.1.2.3 Germany: Europe Point of Care Diagnostics Market Breakdown, by End User
  • 10.1.1.3 France: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 France: Europe Point of Care Diagnostics Market Breakdown, by Product
    • 10.1.1.3.2 France: Europe Point of Care Diagnostics Market Breakdown, by Prescription Mode
    • 10.1.1.3.3 France: Europe Point of Care Diagnostics Market Breakdown, by End User
  • 10.1.1.4 Russia: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Point of Care Diagnostics Market Breakdown, by Product
    • 10.1.1.4.2 Russia: Europe Point of Care Diagnostics Market Breakdown, by Prescription Mode
    • 10.1.1.4.3 Russia: Europe Point of Care Diagnostics Market Breakdown, by End User
  • 10.1.1.5 Italy: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Point of Care Diagnostics Market Breakdown, by Product
    • 10.1.1.5.2 Italy: Europe Point of Care Diagnostics Market Breakdown, by Prescription Mode
    • 10.1.1.5.3 Italy: Europe Point of Care Diagnostics Market Breakdown, by End User
  • 10.1.1.6 Rest of Europe: Europe Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Point of Care Diagnostics Market Breakdown, by Product
    • 10.1.1.6.2 Rest of Europe: Europe Point of Care Diagnostics Market Breakdown, by Prescription Mode
    • 10.1.1.6.3 Rest of Europe: Europe Point of Care Diagnostics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Point of Care Diagnostics Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 BD
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 bioMerieux SA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 BIO-RAD LABORATORIES INC.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Danaher
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 F. HOFFMANN-LA ROCHE LTD.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Johnson and Johnson Services, Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Nova Biomedical
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Polymer Technology Systems, Inc. (PTS)
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Siemens AG
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - E Market

  1. Abbott
  2. BD
  3. bioMerieux SA
  4. BIO-RAD LABORATORIES INC.
  5. Danaher
  6. F. HOFFMANN-LA ROCHE LTD.
  7. Johnson and Johnson Services, Inc.
  8. Nova Biomedical
  9. Polymer Technology Systems, Inc. (PTS)
  10. Siemens AG